2009-11-06 16:17:49 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Bruker BioSciences Corporation and produced a report, rating the company's attractiveness to long-term investors.

Ilhavo, Portugal – 06/11/2009 – SADIF Investment Analytics, announces a new summary due diligence report covering Bruker BioSciences Corporation (BRKR). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Bruker BioSciences Corporation investor.

Report Summary: Bruker BioSciences Corporation is an average quality company with a neutral outlook. Bruker BioSciences Corporation has strong

business growth and is run by passable management. When compared to its closest peer, Beckman Coulter, Inc., Bruker BioSciences Corporation shows less overvaluation and is equally likely to underperform the market.

The 8-page report breaks down the Total StockMark into its three components – business, management and price, performing an in-depth analysis of Bruker BioSciences Corporation for long-term investors.

The report has been distributed to Reuters, and forwarded to Yahoo Finance and FT.com. It is available under 'Analyst Reports' from these websites, from multiple professional platforms including Reuters Knowledge, TheMarkets.com, Thomson Research and Capital IQ or directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company.php?tickerr=BRKR&cod_c ..

About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.